Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally-Induced Cardiorenal Syndrome

BACKGROUND: Sacubitril/Valsartan (Sac/Val), a combined angiotensin-II receptor blocker (Val) and neprilysin inhibitor (Sac) in a 1:1 molar ratio, was shown to reduce the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and reduced LV ejection fraction (EF). This...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Card Fail
Hlavní autoři: Sabbah, Hani N., Zhang, Kefei, Gupta, Ramesh C., Jiang-Xu, Singh-Gupta, Vinita
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704862/
https://ncbi.nlm.nih.gov/pubmed/32841710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2020.08.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky